메뉴 건너뛰기
Nephrology Dialysis Transplantation
Volumn 20, Issue 9, 2005, Pages 2011-2012
Thalidomine for the nephrologist [3]
Author keywords

Arm paralysis; Arteriovenous fistula; Hemodialysis
Indexed keywords

THALIDOMIDE; ANGIOGENESIS INHIBITOR;
EID: 24044500960     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfi015     Document Type: Letter
Times cited : (8)
References (7)
  • 1
    • 0025306776 scopus 로고
    • The potential use of thalidomide in the therapy of graft-versus-host disease. A review of clinical and laboratory information
    • Wood PMD, Proctor S. The potential use of thalidomide in the therapy of graft-versus-host disease. A review of clinical and laboratory information. Leukemia Res 1990; 14: 395-399
    • (1990) Leukemia Res. , vol.14 , pp. 395-399
    • Wood, P.M.D.1    Proctor, S.2
  • 2
    • 0023662703 scopus 로고
    • Determination of thalidomide and its major metabolites by high-performance liquid chromatography
    • Czejka MJ, Koch HP. Determination of thalidomide and its major metabolites by high-performance liquid chromatography. J Chromatogr 1987; 413: 181-187
    • (1987) J. Chromatogr. , vol.413 , pp. 181-187
    • Czejka, M.J.1    Koch, H.P.2
  • 3
    • 0024402108 scopus 로고
    • Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers
    • Chen TL, Vogelsang GB, Petty BG et al. Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers. Drug Metab Dispos 1989; 17: 402
    • (1989) Drug Metab. Dispos. , vol.17 , pp. 402
    • Chen, T.L.1    Vogelsang, G.B.2    Petty, B.G.3
  • 4
    • 0026561179 scopus 로고
    • Thalidomide in human immunodeficiency virus (HIV) patients: A review of safety considerations
    • Gunzler V. Thalidomide in human immunodeficiency virus (HIV) patients: A review of safety considerations. Drugs 1992; 7: 116-134
    • (1992) Drugs , vol.7 , pp. 116-134
    • Gunzler, V.1
  • 5
    • 0041742244 scopus 로고    scopus 로고
    • Thalidomide treatment for immunoglobulin D multiple myeloma in a patient on chronic hemodialysis
    • Hayashi T, Yamaguchi I, Saitoh H, Takagi M, Nonaka Y, Nomura T. Thalidomide treatment for immunoglobulin D multiple myeloma in a patient on chronic hemodialysis. Intern Med 2003; 42: 605-608
    • (2003) Intern. Med. , vol.42 , pp. 605-608
    • Hayashi, T.1    Yamaguchi, I.2    Saitoh, H.3    Takagi, M.4    Nonaka, Y.5    Nomura, T.6
  • 6
    • 0038007193 scopus 로고    scopus 로고
    • Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia
    • Harris E, Behrens J, Samson D, Rahemtulla A, Russell NH, Byrne JL. Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia. Br J Haematol 2003; 122: 160-161
    • (2003) Br. J. Haematol. , vol.122 , pp. 160-161
    • Harris, E.1    Behrens, J.2    Samson, D.3    Rahemtulla, A.4    Russell, N.H.5    Byrne, J.L.6
  • 7
    • 0028363339 scopus 로고
    • Thalidomide for the treatment of uremic pruritus: A crossover randomized double-blind trial
    • Silva SR, Viana PC, Lugon NV, Hoette M, Ruzany F, Lugon JR. Thalidomide for the treatment of uremic pruritus: A crossover randomized double-blind trial. Nephron 1994; 67: 270-273
    • (1994) Nephron , vol.67 , pp. 270-273
    • Silva, S.R.1    Viana, P.C.2    Lugon, N.V.3    Hoette, M.4    Ruzany, F.5    Lugon, J.R.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.